SCHEMBL28292803

SCHEMBL28292803

CC(C)(C)N1CCC(=Cc2ccc(N)cc2F)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SRD5A2 P31213 4/20 0.36
▸ PROKR1 Q8TCW9 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ NR1H2 P55055 1/20 0.31
▸ GRIN2D O15399 1/20 0.30
▸ GRIN3B O60391 1/20 0.30
▸ CHRM2 P08172 1/20 0.30
▸ CHRM1 P11229 1/20 0.30
▸ OPRM1 P35372 1/20 0.30
▸ GRIN1 Q05586 1/20 0.30
▸ KCNH2 Q12809 1/20 0.30
▸ GRIN2A Q12879 1/20 0.30
▸ GRIN2B Q13224 1/20 0.30
▸ GRIN2C Q14957 1/20 0.30
▸ GRIN3A Q8TCU5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28291347 0.81 SRD5A2 (0.35) SRD5A2PROKR1
SCHEMBL20971740 0.78 NR1H2 (0.55) SRD5A2MAPTNR1H2
SCHEMBL11364687 0.70 MAPT (0.60) ALDH1A1LMNAMAPTMAPK1GFER
SCHEMBL274525 0.69 NR1H2 (0.50) ALDH1A1MAPTMAPK1GFERNR1H2
SCHEMBL29959037 0.69 NR1H2 (0.50) ALDH1A1MAPTMAPK1GFERNR1H2
SCHEMBL15536669 0.69 PROKR1 (0.32) PROKR1ALDH1A1MAPK1
SCHEMBL15530574 0.68 HTR1D (0.39) ALDH1A1LMNAMAPTMAPK1GFER
SCHEMBL28291353 0.66 MC4R (0.31) —
SCHEMBL17713023 0.65 GRIN2D (0.44) SRD5A2ALDH1A1LMNAMAPTGRIN2D
SCHEMBL4245359 0.64 SMN1; SMN2 (0.45) SRD5A2NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109661392-A For treating the mitochondrial inhibitors of proliferative disorder 巴斯利尔药物国际股份公司 2019-04-19 — — CN disclosed
Send feedback